3-Hydroxy-3-methylglutaric Acid

If your body has a problem breaking down leucine, one of the protein building blocks in food, or making ketones for energy, this acid can show up in your urine in unusual amounts. Catching that pattern early matters because the underlying conditions can be silent for years and then suddenly cause a metabolic crisis during illness, fasting, or stress.

3-HMG (3-hydroxy-3-methylglutaric acid) sits at the crossroads of two important fuel systems in your body, and changes in your urine level can be one of the earliest hints that something is off in either one. Most people will never need this test, but for the right person it provides a window into metabolism that no routine panel offers.

What This Molecule Actually Reflects

3-HMG is a small organic acid that comes from a busy intersection in your cells. Two pathways converge there: one that breaks down leucine from dietary protein, and another that converts fats into ketones, which are an emergency fuel your brain and heart can burn when blood sugar is low.

An enzyme called HMG-CoA lyase normally finishes the job at that intersection, splitting the precursor molecule into acetoacetate (a ketone) and acetyl-CoA (a basic cellular fuel unit). When that enzyme is impaired or when the broader cellular energy machinery (the mitochondria, which are the energy compartments inside your cells) is struggling, the precursor backs up and gets converted into 3-HMG, which then spills into the urine.

Because of this, an elevated urinary 3-HMG is not just a number. It is a signal about how well your cells are handling protein breakdown and emergency fuel production, particularly during times of stress.

Why It Matters: HMG-CoA Lyase Deficiency

The most established use of this test is to help diagnose a rare inherited condition called HMG-CoA lyase deficiency. People with this condition cannot finish making ketones or fully break down leucine, so during illness or fasting they can develop dangerously low blood sugar without the normal rise in ketones, along with body-wide acid buildup, vomiting, lethargy, and in severe cases coma.

In affected infants, urinary 3-HMG can run hundreds to thousands of times higher than what is typically seen in unaffected individuals. Average urinary levels in patients have been reported around 1,300 mmol/mol creatinine, rising sharply during acute crises. Most cases present in the first year of life, with roughly 40% appearing in the newborn period. Reported neurologic outcomes vary across cohorts: a systematic review of 211 patients found about 63% achieved normal neurologic development with treatment, while a separate series of 37 patients reported closer to 50%.

Adults can also carry milder forms of this condition that went unrecognized in childhood. If you have a family history of unexplained infant deaths, hypoglycemic episodes, or Reye-like illness, this is one test that can clarify whether a metabolic vulnerability is part of your story.

Mitochondrial Dysfunction and Related Disorders

3-HMG and its chemical cousins (3-methylglutaconic acid, 3-methylglutaric acid, 3-hydroxyisovaleric acid) also rise in a broader group of mitochondrial diseases, where the energy compartments inside your cells are not working properly. A large review of 977 patients found that elevated urinary 3-methylglutaconic acid, a separate but biochemically related metabolite, was a recurring feature across many mitochondrial syndromes involving hearing loss, white matter changes in the brain, and basal ganglia involvement. 3-methylglutaconic acid and 3-HMG are distinct molecules with different diagnostic implications, so a 3-HMG result should not be interpreted as if it were a 3-methylglutaconic acid result, but the two are often abnormal together.

In a study of children with autism spectrum disorder, those with signs of mitochondrial respiratory chain dysfunction had elevated urinary 3-HMG together with 3-methylglutaconic and ethylmalonic acids. This finding does not mean 3-HMG causes autism, but it does suggest that a subset of people with autism may have measurable mitochondrial issues that show up in this panel.

A Window Into Prostate Cancer Metabolism

A separate line of research has found that 3-HMG measured in blood (not urine) can help distinguish prostate cancer from benign prostate conditions. In one serum-based study, 3-HMG separated prostate cancer cases from controls with an area under the curve (a measure of how well a marker discriminates two groups, where 1.0 is perfect and 0.5 is no better than chance) of about 0.80, and it separated prostate cancer from prostatitis with a similar area under the curve of about 0.82. In that work 3-HMG was studied alongside several other metabolites rather than as a standalone test.

This evidence comes from blood testing, not the urine test described here. The two are not interchangeable. The urine measurement has not been validated for prostate cancer detection, and you should not order this urine test for that purpose. The serum finding is included here only to give a sense of how this metabolite is being explored in cancer biology.

Where This Test Sits in Clinical Maturity

This is a research and specialty marker, not a routine wellness panel. There are no widely standardized adult reference ranges that apply across labs and populations. Outside of the rare metabolic disorders described above, no large studies have shown that knowing your urinary 3-HMG predicts heart disease, diabetes, cancer, or general mortality. If a clinic markets this as a longevity or general health metric, treat that claim with skepticism. The honest framing is that it gives a focused read on one specific corner of metabolism.

Why a Single Reading Can Mislead You

Several real-world factors can shift a single measurement, and knowing them helps you interpret your number correctly:

• Recent illness or infection: in people with underlying metabolic vulnerability, an infection or vomiting episode can drive 3-HMG sharply higher within hours. Testing during or right after an acute illness can give a falsely alarming picture.
• Prolonged fasting: going many hours without eating ramps up fat breakdown for energy, which can raise 3-HMG even in people without an inherited enzyme problem. A test done after an unintentional overnight fast plus a missed breakfast is not a stable baseline.
• Newborn status: newborns normally excrete relatively large amounts of 3-HMG along with related acids; these levels are not interpreted the same way as in older children or adults.
• Intermittent excretion: in some mitochondrial syndromes, 3-HMG and its relatives come and go. A single normal reading does not rule out an underlying issue if the clinical suspicion is high.

Routine physiological influences on this marker in healthy adults (age, sex, body weight, kidney function) have not been systematically studied. That gap is itself a reason to interpret a single reading cautiously.

Why One Reading Is Not Enough

Because this metabolite responds to short-term metabolic stress and can vary intermittently in mitochondrial syndromes, a single measurement is a snapshot, not a trend. If your first result is elevated, a reasonable approach is to repeat it in a stable, well-fed state several weeks later before drawing conclusions. Retesting intervals are not set by published guidelines and should be individualized with your clinician based on the reason you are testing and whether you are making dietary or treatment changes.

Trending matters more than any single number because the same person can show very different values during illness versus stable health. A series of readings tells you whether the elevation is a one-time spike from an acute event or a persistent pattern that warrants deeper workup.

What to Do If Your Result Is Unexpected

If your urinary 3-HMG comes back elevated, the next step is rarely treatment in isolation. It is usually broader testing to put the number in context.

Sensible companions include a full urine organic acid panel (to see whether 3-methylglutaconic, 3-methylglutaric, 3-hydroxyisovaleric, and glutaric acids are also elevated, which tightens the diagnostic picture), a blood acylcarnitine profile (particularly looking at a marker called C5-OH, which can signal HMG-CoA lyase deficiency and several other related disorders), and depending on the pattern, genetic testing of relevant genes or an enzyme activity assay performed on a blood or skin sample.

Persistent elevations or a pattern suggestive of a specific metabolic syndrome are best worked up with a metabolic specialist (a clinician who focuses on inborn errors of metabolism) or a medical geneticist. If you have a family history of metabolic disease or unexplained infant illness, a genetic counselor can help you decide what additional testing is most useful for you and for relatives.

A modestly elevated single reading in an otherwise healthy adult, with no symptoms and no family history, usually warrants a repeat measurement in stable conditions before pursuing aggressive workup. A pattern of repeated elevations, especially with related acids, is what should trigger formal evaluation.